Back to Blog
Ethics and the Aftermath of Genetic Diagnosis
Monday, Apr. 28, 2014
Last year, actress Angelina Jolie decided on a double mastectomy after learning she had a gene disposing her to breast cancer. Her story is one instance of what is happening to many who, with the benefit of new gene-identifying tools, are having to confront hard personal and ethical questions about medical treatment in the aftermath of genetic diagnoses.
This panel of SCU scholars will explore the ethical, medical, communication, gender, and biological aspects of such scenarios. Laura Ellingson, SCU Communications, Angel Islas, SCU Biology, and Karen Peterson-Iyer, SCU Religious Studies, are the panelists.
This Health & Science Horizons Program is sponsored by Markkula Center for Applied Ethics in partnership with the Gerald and Sally DeNardo Lectureship.